韩国做爰无遮A片床戏,第一财经电视直播,女人18毛片水真多,老头猛吸女大学奶头A片,借种灭门案完整观看国语

Clinical Hemorheology And Microcirculation
收藏雜(za)志
  • 數據庫(ku)收錄SCIE
  • 創刊(kan)年(nian)份(fen)1997年
  • 年發文量112
  • H-index48

Clinical Hemorheology And Microcirculation

期刊中文名:臨床血液流變學和微(wei)循環(huan)ISSN:1386-0291E-ISSN:1875-8622

該(gai)雜(za)志(zhi)國際簡稱:CLIN HEMORHEOL MICRO,是由出(chu)版商IOS Press出(chu)版的(de)(de)(de)一本(ben)致(zhi)力于發(fa)布醫(yi)學(xue)(xue)研(yan)(yan)(yan)(yan)(yan)究(jiu)新(xin)(xin)成果(guo)的(de)(de)(de)的(de)(de)(de)專業(ye)學(xue)(xue)術(shu)(shu)(shu)期刊(kan)。該(gai)雜(za)志(zhi)以HEMATOLOGY研(yan)(yan)(yan)(yan)(yan)究(jiu)為重(zhong)點(dian),主要發(fa)表刊(kan)登有(you)創見的(de)(de)(de)學(xue)(xue)術(shu)(shu)(shu)論(lun)(lun)文(wen)文(wen)章、行業(ye)最新(xin)(xin)科研(yan)(yan)(yan)(yan)(yan)成果(guo),扼要報(bao)道階段性研(yan)(yan)(yan)(yan)(yan)究(jiu)成果(guo)和(he)重(zhong)要研(yan)(yan)(yan)(yan)(yan)究(jiu)工(gong)作的(de)(de)(de)最新(xin)(xin)進展(zhan)(zhan),選載對(dui)學(xue)(xue)科發(fa)展(zhan)(zhan)起指導作用的(de)(de)(de)綜述與專論(lun)(lun),促進學(xue)(xue)術(shu)(shu)(shu)發(fa)展(zhan)(zhan),為廣大讀者(zhe)服(fu)務(wu)。該(gai)刊(kan)是一本(ben)國際優秀(xiu)雜(za)志(zhi),在(zai)國際上有(you)很高的(de)(de)(de)學(xue)(xue)術(shu)(shu)(shu)影響力。

基本信息:
期刊簡稱:CLIN HEMORHEOL MICRO
是(shi)否OA:未開放
是否預(yu)警:
Gold OA文章(zhang)占(zhan)比(bi):8.45%
出版信息:
出版地區:NETHERLANDS
出(chu)版周期:Bimonthly
出(chu)版語言:English
出版(ban)商:IOS Press
評價信息:
中科院分區:4區
JCR分區:Q3
影響因子(zi):2.1
CiteScore:4.3
雜志介紹(shao) 中科院(yuan)JCR分區 JCR分區 CiteScore 投稿(gao)經驗

雜志介紹

Clinical Hemorheology And Microcirculation雜志介紹

《Clinical Hemorheology And Microcirculation》是(shi)一本(ben)(ben)以(yi)English為主的(de)(de)未開放獲取國際優秀期(qi)刊(kan),中文名稱臨床血液流變學(xue)和微循環,本(ben)(ben)刊(kan)主要出版、報(bao)道醫學(xue)-HEMATOLOGY領域的(de)(de)研(yan)究動態以(yi)及在該領域取得(de)的(de)(de)各方面的(de)(de)經驗(yan)和科研(yan)成果,介紹該領域有關本(ben)(ben)專(zhuan)業的(de)(de)最(zui)新進展(zhan),探討行(xing)業發展(zhan)的(de)(de)思路和方法(fa),以(yi)促進學(xue)術信息交(jiao)流,提高(gao)行(xing)業發展(zhan)。該刊(kan)已(yi)被國際權威數據庫SCIE收錄,為該領域相關學(xue)科的(de)(de)發展(zhan)起(qi)到(dao)了(le)良(liang)好的(de)(de)推動作用,也得(de)到(dao)了(le)本(ben)(ben)專(zhuan)業人員的(de)(de)廣泛(fan)認(ren)可(ke)。該刊(kan)最(zui)新影響因子(zi)為2.1,最(zui)新CiteScore 指數為4.3。

本刊近期(qi)中(zhong)國學者發表的論文主要有(you):

  • Circ_0091822 aggravates ox-LDL-induced endothelial cell injury through targeting the miR-661/RAB22A axis

    Author: Zhu, Lingfeng; Zhao, Ping; Meng, Xianwei; Jin, Hong; Tuo, Baojuan

  • Nomogram based on preoperative conventional ultrasound and shear wave velocity for predicting central lymph node metastasis in papillary thyroid carcinoma

    Author: Zhong, Lichang; Xie, Juan; Shi, Lin; Gu, Liping; Bai, Wenkun

  • Influence factors on registration of three-dimensional contrast-enhanced ultrasound fusion imaging in evaluating the ablative margin - A phantom study

    Author: Zheng, Ruiying; Ye, Jieyi; Zhang, Xiaoer; Zhou, Xiaoyu; Huang, Tongyi; Xu, Ming; Cong, Longfei; Xie, Xiaoyan; Huang, Guangliang

  • The value of contrast-enhanced ultrasound in the diagnosis of BI-RADS-US 4a lesions less than 2 cm in diameter

    Author: Yu, Mei-qin; Zhang, Li-li; Jiang, Li-ping; Zhou, Ai-yun

英文介紹

Clinical Hemorheology And Microcirculation雜志英文介紹

Clinical Hemorheology and Microcirculation, a peer-reviewed international scientific journal, serves as an aid to understanding the flow properties of blood and the relationship to normal and abnormal physiology. The rapidly expanding science of hemorheology concerns blood, its components and the blood vessels with which blood interacts. It includes perihemorheology, i.e., the rheology of fluid and structures in the perivascular and interstitial spaces as well as the lymphatic system. The clinical aspects include pathogenesis, symptomatology and diagnostic methods, and the fields of prophylaxis and therapy in all branches of medicine and surgery, pharmacology and drug research.

The endeavour of the Editors-in-Chief and publishers of Clinical Hemorheology and Microcirculation is to bring together contributions from those working in various fields related to blood flow all over the world. The editors of Clinical Hemorheology and Microcirculation are from those countries in Europe, Asia, Australia and America where appreciable work in clinical hemorheology and microcirculation is being carried out. Each editor takes responsibility to decide on the acceptance of a manuscript. He is required to have the manuscript appraised by two referees and may be one of them himself. The executive editorial office, to which the manuscripts have been submitted, is responsible for rapid handling of the reviewing process.

Clinical Hemorheology and Microcirculation accepts original papers, brief communications, mini-reports and letters to the Editors-in-Chief. Review articles, providing general views and new insights into related subjects, are regularly invited by the Editors-in-Chief. Proceedings of international and national conferences on clinical hemorheology (in original form or as abstracts) complete the range of editorial features.

中科院SCI分區

Clinical Hemorheology And Microcirculation雜志中科院分區信息

2023年12月升(sheng)級版
綜述:
TOP期刊:
大類:醫學 4區
小類:

HEMATOLOGY
血液學 4區

PERIPHERAL VASCULAR DISEASE
外周血管病 4區

2022年12月(yue)升級版
綜述:否(fou)
TOP期刊:
大類:醫學 4區
小類:

HEMATOLOGY
血液學 4區

PERIPHERAL VASCULAR DISEASE
外周血管病 4區

2021年12月舊的升級版
綜述:
TOP期刊:
大類:醫學 4區
小類:

HEMATOLOGY
血液學 4區

PERIPHERAL VASCULAR DISEASE
外周血管病 4區

2021年12月基(ji)礎版
綜述:
TOP期刊:
大類:醫學 4區
小類:

HEMATOLOGY
血液學 4區

PERIPHERAL VASCULAR DISEASE
外周血管病 4區

2021年(nian)12月升級版
綜述:
TOP期刊:
大類:醫學 4區
小類:

HEMATOLOGY
血液學 4區

PERIPHERAL VASCULAR DISEASE
外周血管病 4區

2020年12月舊的升級版(ban)
綜述:
TOP期刊:
大類:醫學 4區
小類:

HEMATOLOGY
血液學 4區

PERIPHERAL VASCULAR DISEASE
外周血管病 4區

中科院SCI分區:是(shi)中(zhong)(zhong)(zhong)國科(ke)(ke)學(xue)院(yuan)文獻情報中(zhong)(zhong)(zhong)心科(ke)(ke)學(xue)計(ji)量中(zhong)(zhong)(zhong)心的科(ke)(ke)學(xue)研究成(cheng)果。期(qi)刊(kan)分(fen)(fen)區(qu)(qu)表(biao)自(zi)2004年(nian)開始發布,延續(xu)至今;2019年(nian)推出(chu)升級(ji)版(ban),實現基礎版(ban)、升級(ji)版(ban)并存過(guo)渡,2022年(nian)只發布升級(ji)版(ban),期(qi)刊(kan)分(fen)(fen)區(qu)(qu)表(biao)數據每(mei)年(nian)底發布。 中(zhong)(zhong)(zhong)科(ke)(ke)院(yuan)分(fen)(fen)區(qu)(qu)為(wei)(wei)4個區(qu)(qu)。中(zhong)(zhong)(zhong)科(ke)(ke)院(yuan)分(fen)(fen)區(qu)(qu)采用刊(kan)物(wu)前3年(nian)影響因子平均值進行分(fen)(fen)區(qu)(qu),即(ji)前5%為(wei)(wei)該(gai)類1區(qu)(qu),6%~20%為(wei)(wei)2區(qu)(qu)、21%~50%為(wei)(wei)3區(qu)(qu),其(qi)余的為(wei)(wei)4區(qu)(qu)。1區(qu)(qu)和2區(qu)(qu)雜志(zhi)很少,雜志(zhi)質量相(xiang)對也高,基本都是(shi)本領域的頂級(ji)期(qi)刊(kan)。

JCR分區(2023-2024年最(zui)新版)

Clinical Hemorheology And Microcirculation雜志 JCR分區信息

按JIF指標學科分(fen)區(qu)
學科:HEMATOLOGY
收錄子集:SCIE
分區:Q3
排名:58 / 97
百分位:

40.7%

學科:PERIPHERAL VASCULAR DISEASE
收錄子集:SCIE
分區:Q3
排名:51 / 96
百分位:

47.4%

按JCI指(zhi)標學科分區
學科:HEMATOLOGY
收錄子集:SCIE
分區:Q2
排名:42 / 97
百分位:

57.22%

學科:PERIPHERAL VASCULAR DISEASE
收錄子集:SCIE
分區:Q2
排名:43 / 96
百分位:

55.73%

JCR分區:JCR分(fen)(fen)區(qu)來自科(ke)(ke)睿唯(wei)安公司,JCR是一(yi)個獨(du)特的(de)多學(xue)科(ke)(ke)期刊(kan)(kan)評價(jia)(jia)工具,為唯(wei)一(yi)提供基于(yu)引文數(shu)據(ju)的(de)統計信(xin)息(xi)的(de)期刊(kan)(kan)評價(jia)(jia)資源(yuan)。每年(nian)(nian)發布的(de)JCR分(fen)(fen)區(qu),設置了254個具體學(xue)科(ke)(ke)。JCR分(fen)(fen)區(qu)根據(ju)每個學(xue)科(ke)(ke)分(fen)(fen)類(lei)按照(zhao)期刊(kan)(kan)當年(nian)(nian)的(de)影(ying)響因子高(gao)低將期刊(kan)(kan)平均(jun)分(fen)(fen)為4個區(qu),分(fen)(fen)別為Q1、Q2、Q3和Q4,各占25%。JCR分(fen)(fen)區(qu)中(zhong)期刊(kan)(kan)的(de)數(shu)量是均(jun)勻分(fen)(fen)為四個部分(fen)(fen)的(de)。

CiteScore 評價數據(2024年最新版)

Clinical Hemorheology And Microcirculation雜志CiteScore 評價數據

  • CiteScore 值:4.3
  • SJR:0.456
  • SNIP:0.561
學科類別 分區 排名 百分位
大類:Medicine 小類:Cardiology and Cardiovascular Medicine Q2 143 / 387

63%

大類:Medicine 小類:Hematology Q2 59 / 137

57%

大類:Medicine 小類:Physiology (medical) Q3 59 / 113

48%

大類:Medicine 小類:Physiology Q3 115 / 193

40%

歷年影響因子和期刊自引率

投稿經驗

Clinical Hemorheology And Microcirculation雜志投稿經驗

該(gai)雜志(zhi)(zhi)是一本國際(ji)優秀(xiu)雜志(zhi)(zhi),在國際(ji)上有較高的學(xue)術影響力,行(xing)業(ye)關(guan)注度很(hen)高,已被國際(ji)權威數(shu)據庫SCIE收錄,該(gai)雜志(zhi)(zhi)在HEMATOLOGY綜合專業(ye)領域(yu)專業(ye)度認可很(hen)高,對稿(gao)(gao)(gao)件(jian)內容的創(chuang)新(xin)性和學(xue)術性要求很(hen)高,作為一本國際(ji)優秀(xiu)雜志(zhi)(zhi),一般投稿(gao)(gao)(gao)過(guo)審(shen)時間都較長,投稿(gao)(gao)(gao)過(guo)審(shen)時間平均 ,如果想(xiang)投稿(gao)(gao)(gao)該(gai)刊要做好(hao)時間安排。版面費(fei)不祥(xiang)。該(gai)雜志(zhi)(zhi)近兩年(nian)未被列(lie)入預警(jing)名單,建議您投稿(gao)(gao)(gao)。如您想(xiang)了解更多投稿(gao)(gao)(gao)政策及投稿(gao)(gao)(gao)方案,請咨(zi)詢(xun)客(ke)服。

免責聲明

若用戶需要出版(ban)服務,請聯系出版(ban)商:IOS PRESS, NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013 BG。